During the past decade, CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf" #1 collaborator was "Ludwig-Maximilians - University of Munich" with 2 trials as a collaborator, "Philipps University Marburg Medical Center" with 2 trials as a collaborator, "Bernhard Nocht Institute for Tropical Medicine" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "German Center for Infection Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf" are "Migraine" (2 trials), "Covid19" (1 trials) and "MERS (Middle East Respiratory Syndrome)" (1 trials). Many other conditions were trialed in "CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf" in a lesser frequency.

Most popular intervention types in "CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf" are "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Comirnaty" (1 trials), "MVA-SARS-2-S vaccinations (days 0 & 28)" (1 trials), "gammaCore®-R" (1 trials), "gammaCore®-R Sham" (1 trials) and "non-invasive vagus nerve stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".